COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper

Ali Farhoudian; Alexander Mario Baldacchino; Nicolas Clark; Gilberto Gerra; Hamed Ekhtiari; Geert Dom; Azarakhsh Mokri; Mandana Sadeghi; Pardris Nematollahi; Maryanne Demasi; Christian G. Schütz; Seyed Mohammadreza Hashemian; Payam Tabarsi; Susanna Galea-Singer; Giuseppe Carrà; Thomas Clausen; Christos Kouimtsidis; Serenella Tolomeo; Seyed Ramin Radfar; Emran Mohammed Razaghi

doi:10.32598/bcn.11.covid19.1

COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper

Ali Farhoudian, Alexander Mario Baldacchino, Nicolas Clark, Gilberto Gerra, Hamed Ekhtiari^*, Geert Dom, Azarakhsh Mokri, Mandana Sadeghi, Pardris Nematollahi, Maryanne Demasi, Christian G. Schütz, Seyed Mohammadreza Hashemian, Payam Tabarsi, Susanna Galea-Singer, Giuseppe Carrà, Thomas Clausen, Christos Kouimtsidis, Serenella Tolomeo, Seyed Ramin Radfar, Emran Mohammed Razaghi

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Abstract

Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).

Original language	English
Pages (from-to)	129-146
Number of pages	17
Journal	Basic and Clinical Neuroscience
Volume	Special Issue on COVID-19
Early online date	12 Apr 2020
DOIs	https://doi.org/10.32598/bcn.11.covid19.1
Publication status	E-pub ahead of print - 12 Apr 2020

Keywords

Coronavirus
Coronavirus disease 2019 (COVID-19)
Pandemic
Public health
Subtance use disorder
Addiction medicine
Harm reduction
Policy
Methadone
Opioid substitution therapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.32598/bcn.11.covid19.1Licence: CC BY-NC

COVID ISAM PPIG Position Paper
Copyright © 2020 The Authors. This is an open access article under the terms of the Creative Commons Attribution NonCommercial License, which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
Final published version, 747 KBLicence: CC BY-NC

Cite this

Farhoudian, A., Baldacchino, A. M., Clark, N., Gerra, G., Ekhtiari, H., Dom, G., Mokri, A., Sadeghi, M., Nematollahi, P., Demasi, M., Schütz, C. G., Hashemian, S. M., Tabarsi, P., Galea-Singer, S., Carrà, G., Clausen, T., Kouimtsidis, C., Tolomeo, S., Radfar, S. R., & Razaghi, E. M. (2020). COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper. Basic and Clinical Neuroscience, Special Issue on COVID-19, 129-146. Advance online publication. https://doi.org/10.32598/bcn.11.covid19.1

@article{7a88aae1b1dc4660ab29c833c99786ce,

title = "COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper",

abstract = "Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).",

keywords = "Coronavirus, Coronavirus disease 2019 (COVID-19), Pandemic, Public health, Subtance use disorder, Addiction medicine, Harm reduction, Policy, Methadone, Opioid substitution therapy",

author = "Ali Farhoudian and Baldacchino, {Alexander Mario} and Nicolas Clark and Gilberto Gerra and Hamed Ekhtiari and Geert Dom and Azarakhsh Mokri and Mandana Sadeghi and Pardris Nematollahi and Maryanne Demasi and Sch{\"u}tz, {Christian G.} and Hashemian, {Seyed Mohammadreza} and Payam Tabarsi and Susanna Galea-Singer and Giuseppe Carr{\`a} and Thomas Clausen and Christos Kouimtsidis and Serenella Tolomeo and Radfar, {Seyed Ramin} and Razaghi, {Emran Mohammed}",

year = "2020",

month = apr,

day = "12",

doi = "10.32598/bcn.11.covid19.1",

language = "English",

volume = "Special Issue on COVID-19",

pages = "129--146",

journal = "Basic and Clinical Neuroscience",

issn = "2228-7442",

publisher = "Iran University of Medical Sciences",

}

Farhoudian, A, Baldacchino, AM, Clark, N, Gerra, G, Ekhtiari, H, Dom, G, Mokri, A, Sadeghi, M, Nematollahi, P, Demasi, M, Schütz, CG, Hashemian, SM, Tabarsi, P, Galea-Singer, S, Carrà, G, Clausen, T, Kouimtsidis, C, Tolomeo, S, Radfar, SR & Razaghi, EM 2020, 'COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper', Basic and Clinical Neuroscience, vol. Special Issue on COVID-19, pp. 129-146. https://doi.org/10.32598/bcn.11.covid19.1

COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper. / Farhoudian, Ali; Baldacchino, Alexander Mario; Clark, Nicolas et al.
In: Basic and Clinical Neuroscience, Vol. Special Issue on COVID-19, 12.04.2020, p. 129-146.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - COVID-19 and substance use disorders

T2 - Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper

AU - Farhoudian, Ali

AU - Baldacchino, Alexander Mario

AU - Clark, Nicolas

AU - Gerra, Gilberto

AU - Ekhtiari, Hamed

AU - Dom, Geert

AU - Mokri, Azarakhsh

AU - Sadeghi, Mandana

AU - Nematollahi, Pardris

AU - Demasi, Maryanne

AU - Schütz, Christian G.

AU - Hashemian, Seyed Mohammadreza

AU - Tabarsi, Payam

AU - Galea-Singer, Susanna

AU - Carrà, Giuseppe

AU - Clausen, Thomas

AU - Kouimtsidis, Christos

AU - Tolomeo, Serenella

AU - Radfar, Seyed Ramin

AU - Razaghi, Emran Mohammed

PY - 2020/4/12

Y1 - 2020/4/12

N2 - Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).

AB - Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).

KW - Coronavirus

KW - Coronavirus disease 2019 (COVID-19)

KW - Pandemic

KW - Public health

KW - Subtance use disorder

KW - Addiction medicine

KW - Harm reduction

KW - Policy

KW - Methadone

KW - Opioid substitution therapy

U2 - 10.32598/bcn.11.covid19.1

DO - 10.32598/bcn.11.covid19.1

M3 - Review article

SN - 2228-7442

VL - Special Issue on COVID-19

SP - 129

EP - 146

JO - Basic and Clinical Neuroscience

JF - Basic and Clinical Neuroscience

ER -

Farhoudian A, Baldacchino AM, Clark N, Gerra G, Ekhtiari H, Dom G et al. COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper. Basic and Clinical Neuroscience. 2020 Apr 12;Special Issue on COVID-19:129-146. Epub 2020 Apr 12. doi: 10.32598/bcn.11.covid19.1

COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this